JPM 2023 Baxter.pdf

1、41STANNUAL J.P.MORGAN HEALTHCARE CONFERENCEJos(Joe)AlmeidaChairman&Chief Executive Of ficerJ A N U A R Y 9,2 0 2 31This presentation includes forward-looking statements concerning the companys financial results and business development,transformation and regulatory activities(including the proposed

2、spinoff of the companys Renal Care and Acute Therapies businesses,the simplified operating model and the potential sale or other strategic transaction involving the companys BioPharma Solutions business).These forward-looking statements are based on assumptions about many important factors,including

3、 the following,which could cause actual results to differ materially from those in the forward-looking statements:the ability to effect the transactions described above and to meet the conditions related thereto;potential uncertainty during the pendency of the transactions that could affect the comp

4、anys financial performance;the possibility that the transactions will not be completed within the anticipated time period or at all;the possibility that the transactions will not achieve their intended benefits;the possibility of disruption,including changes to existing business and employee relatio

5、nships,disputes,litigation or unanticipated costs in connection with the transactions;uncertainty of the expected financial performance of the company or the new kidney care company following completion of the spinoff transaction;negative effects of the announcement or pendency of the transactions o

6、n the market price of the companys securities or on the financial performance of the company;evolving legal,regulatory and tax regimes;changes in general economic and/or industry specific conditions;actions by third parties,including government agencies;demand for and market acceptance of risks for